UBS Group’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.42M | Buy |
277,102
+123,767
| +81% | +$634K | ﹤0.01% | 4088 |
|
|
2025
Q1 | $210K | Sell |
153,335
-261,138
| -63% | -$358K | ﹤0.01% | 5287 |
|
|
2024
Q4 | $1.28M | Sell |
414,473
-26,358
| -6% | -$81.4K | ﹤0.01% | 4055 |
|
|
2024
Q3 | $3.39M | Buy |
440,831
+289,516
| +191% | +$2.23M | ﹤0.01% | 2588 |
|
|
2024
Q2 | $1.3M | Sell |
151,315
-6,911
| -4% | -$59.3K | ﹤0.01% | 3188 |
|
|
2024
Q1 | $1.26M | Buy |
+158,226
| New | +$1.26M | ﹤0.01% | 3387 |
|
|
2023
Q4 | – | Sell |
-30,988
| Closed | -$349K | – | 8553 |
|
|
2023
Q3 | $349K | Sell |
30,988
-147
| -0.5% | -$1.66K | ﹤0.01% | 3860 |
|
|
2023
Q2 | $103K | Buy |
31,135
+10,643
| +52% | +$35.3K | ﹤0.01% | 4938 |
|
|
2023
Q1 | $80.9K | Buy |
20,492
+4,031
| +24% | +$15.9K | ﹤0.01% | 5028 |
|
|
2022
Q4 | $119K | Buy |
+16,461
| New | +$119K | ﹤0.01% | 4829 |
|
|
2022
Q3 | – | Sell |
-19,225
| Closed | -$87K | – | 9690 |
|
|
2022
Q2 | $87K | Buy |
19,225
+17,175
| +838% | +$77.7K | ﹤0.01% | 4536 |
|
|
2022
Q1 | $16K | Sell |
2,050
-534
| -21% | -$4.17K | ﹤0.01% | 6710 |
|
|
2021
Q4 | $28K | Buy |
+2,584
| New | +$28K | ﹤0.01% | 6351 |
|
|
2021
Q3 | – | Sell |
-3,259
| Closed | -$37K | – | 8781 |
|
|
2021
Q2 | $37K | Buy |
3,259
+460
| +16% | +$5.22K | ﹤0.01% | 5650 |
|
|
2021
Q1 | $31K | Buy |
2,799
+1,651
| +144% | +$18.3K | ﹤0.01% | 5979 |
|
|
2020
Q4 | $13K | Sell |
1,148
-150
| -12% | -$1.7K | ﹤0.01% | 6273 |
|
|
2020
Q3 | $13K | Buy |
+1,298
| New | +$13K | ﹤0.01% | 5773 |
|